Anteilseigner
CDH Investments Management (Hong Kong) Ltd. (9,95 %) GL Capital Group (9,84 %) UBS Asset Management Switzerland AG (6,14 %) Jinyao Development Co. Ltd. (5,30 %) Ascendent Capital Partners (China) Ltd. (4,75 %) Zhong Geng Fund Management Co. , Ltd. (3,22 %) The Vanguard Group, Inc. (2,17 %) Juli Information Consulting (Beijing) Co. Ltd. (1,91 %) Foresight Fund Management Co., Ltd. (1,30 %) E Fund Management Co., Ltd. (1,19 %) GF Fund Management Co., Ltd. (0,79 %) Fullgoal Fund Management Co., Ltd. (0,76 %) Zhong Ou Asset Management Co., Ltd (0,64 %) BlackRock Fund Advisors (0,48 %) Bosera Asset Management Co., Ltd. (0,43 %) China Universal Asset Management Co., Ltd. (0,31 %) Cambria Investment Management LP (0,27 %) American Century Investment Management, Inc. (0,18 %)
Kontakt
SCICLONE PHARMACEUTICALS (HLDGS) LT